Literature DB >> 26140245

Deficient regulatory B cells in human chronic graft-versus-host disease.

Adèle de Masson1, Gérard Socié2, Martine Bagot1, Armand Bensussan3, Jean-David Bouaziz1.   

Abstract

Human chronic graft-versus-host disease (cGVHD) is a frequent and disabling complication of allogeneic hematopoietic stem cell transplantation. Regulatory B cells (Bregs) are IL-10-producing B cells that are able to inhibit the innate and adaptive immune responses. We have recently demonstrated a defect in regulatory B cells in human cGVHD.

Entities:  

Keywords:  allogeneic stem cell transplantation; chronic graft-versus-host disease; interleukin-10; regulatory B cells

Year:  2015        PMID： 26140245      PMCID： PMC4485800          DOI： 10.1080/2162402X.2015.1016707

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  10 in total

Review 1.  B cells in chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Bruce R Blazar; Corey Cutler; Jerome Ritz
Journal:  Biol Blood Marrow Transplant       Date:  2014-11-12       Impact factor: 5.742

2.  Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

Authors:  Yohei Iwata; Takashi Matsushita; Mayuka Horikawa; David J Dilillo; Koichi Yanaba; Guglielmo M Venturi; Paul M Szabolcs; Steven H Bernstein; Cynthia M Magro; Armistead D Williams; Russell P Hall; E William St Clair; Thomas F Tedder
Journal:  Blood       Date:  2010-10-20       Impact factor: 22.113

3.  IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro.

Authors:  Jean-David Bouaziz; Sebastien Calbo; Maud Maho-Vaillant; Anne Saussine; Martine Bagot; Armand Bensussan; Philippe Musette
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

4.  CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease.

Authors:  Adèle de Masson; Jean-David Bouaziz; Hélène Le Buanec; Marie Robin; Alix O'Meara; Nathalie Parquet; Michel Rybojad; Estelle Hau; Jean-Benoît Monfort; Mylène Branchtein; David Michonneau; Valérie Dessirier; Flore Sicre de Fontbrune; Anne Bergeron; Raphaël Itzykson; Nathalie Dhédin; Djaouida Bengoufa; Régis Peffault de Latour; Aliénor Xhaard; Martine Bagot; Armand Bensussan; Gérard Socié
Journal:  Blood       Date:  2015-01-20       Impact factor: 22.113

5.  B cells regulate autoimmunity by provision of IL-10.

Authors:  Simon Fillatreau; Claire H Sweenie; Mandy J McGeachy; David Gray; Stephen M Anderton
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

6.  A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

Authors:  Koichi Yanaba; Jean-David Bouaziz; Karen M Haas; Jonathan C Poe; Manabu Fujimoto; Thomas F Tedder
Journal:  Immunity       Date:  2008-05       Impact factor: 31.745

7.  CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Authors:  Paul A Blair; Lina Yassin Noreña; Fabian Flores-Borja; David J Rawlings; David A Isenberg; Michael R Ehrenstein; Claudia Mauri
Journal:  Immunity       Date:  2010-01-14       Impact factor: 31.745

Review 8.  Current issues in chronic graft-versus-host disease.

Authors:  Gérard Socié; Jerome Ritz
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

9.  IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.

Authors:  Ping Shen; Toralf Roch; Vicky Lampropoulou; Richard A O'Connor; Ulrik Stervbo; Ellen Hilgenberg; Stefanie Ries; Van Duc Dang; Yarúa Jaimes; Capucine Daridon; Rui Li; Luc Jouneau; Pierre Boudinot; Siska Wilantri; Imme Sakwa; Yusei Miyazaki; Melanie D Leech; Rhoanne C McPherson; Stefan Wirtz; Markus Neurath; Kai Hoehlig; Edgar Meinl; Andreas Grützkau; Joachim R Grün; Katharina Horn; Anja A Kühl; Thomas Dörner; Amit Bar-Or; Stefan H E Kaufmann; Stephen M Anderton; Simon Fillatreau
Journal:  Nature       Date:  2014-02-23       Impact factor: 49.962

10.  Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.

Authors:  Ahmad Khoder; Anushruti Sarvaria; Abdullah Alsuliman; Claude Chew; Takuya Sekine; Nichola Cooper; Stephan Mielke; Hugues de Lavallade; Muharrem Muftuoglu; Irina Fernandez Curbelo; Enli Liu; Paolo A Muraro; Amin Alousi; Kate Stringaris; Simrit Parmar; Nina Shah; Hila Shaim; Eric Yvon; Jeffrey Molldrem; Rayne Rouce; Richard Champlin; Ian McNiece; Claudia Mauri; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood       Date:  2014-07-22       Impact factor: 22.113
  10 in total
  6 in total

1.  Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.

Authors:  Kathy S Wang; Haesook T Kim; Sarah Nikiforow; Alexander T Heubeck; Vincent T Ho; John Koreth; Edwin P Alyea; Philippe Armand; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Corey S Cutler; Jerome Ritz
Journal:  Blood       Date:  2017-11-14       Impact factor: 22.113

Review 2.  B cell regulation of the anti-tumor response and role in carcinogenesis.

Authors:  Marc Schwartz; Yu Zhang; Joseph D Rosenblatt
Journal:  J Immunother Cancer       Date:  2016-07-19       Impact factor: 13.751

Review 3.  New Answers to Old Conundrums: What Antibodies, Exosomes and Inflammasomes Bring to the Conversation. Canadian National Transplant Research Program International Summit Report.

Authors:  Mélanie Dieudé; Lori J West; Daniel A Muruve; Lakshman Gunaratnam; Thalachallour Mohanakumar; Emmanuel Zorn; Christopher W Cairo; Darren H Freed; Kirk R Schultz; Robert L Fairchild; Marie-Josée Hébert
Journal:  Transplantation       Date:  2018-02       Impact factor: 4.939

Review 4.  B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Mateja Kralj Juric; Maxim Shevtsov; Petra Mozes; Justyna Ogonek; Rachel E Crossland; Anne M Dickinson; Hildegard T Greinix; Ernst Holler; Eva M Weissinger; Gabriele Multhoff
Journal:  Front Immunol       Date:  2017-01-16       Impact factor: 7.561

5.  The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study.

Authors:  Xiya Wei; Yiyu Xie; Ruoyu Jiang; Huiyu Li; Heqing Wu; Yuqi Zhang; Ling Li; Shiyuan Zhou; Xiao Ma; Zaixiang Tang; Jun He; Depei Wu; Xiaojin Wu
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

6.  IL-10 producing regulatory B cells are decreased in blood from smokers and COPD patients.

Authors:  Merel Jacobs; Sven Verschraegen; Bihiyga Salhi; Jasper Anckaert; Pieter Mestdagh; Guy G Brusselle; Ken R Bracke
Journal:  Respir Res       Date:  2022-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.